The distribution and common amino acid polymorphisms of human papillomavirus (HPV)-31 variants in 2700 women from Northern China.

Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil. Biomed Res Int (2015) 0.79

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36

TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Classification of papillomaviruses. Virology (2004) 14.16

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29

Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis (2010) 4.42

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell (1991) 3.58

Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst (2006) 2.67

The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J (1990) 2.57

The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07

The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol (1994) 1.97

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One (2011) 1.80

Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst (2001) 1.72

Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer (2006) 1.65

Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv (1992) 1.63

High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer (2007) 1.47

Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer (2007) 1.46

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med (1995) 1.29

Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol (1996) 1.21

Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology (2004) 1.16

Susceptibility to cervical cancer: an overview. Gynecol Oncol (2012) 1.07

The Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system. PLoS One (2012) 1.03

Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression. Important Adv Oncol (1991) 0.98

Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol (1994) 0.98

Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol (2005) 0.96

A new PCR-based mass spectrometry system for high-risk HPV, part I: methods. Am J Clin Pathol (2011) 0.94

Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Int J Cancer (2012) 0.92

Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J Med Virol (2009) 0.92

Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage. Int J Cancer (2012) 0.90

New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil. Gynecol Oncol (2011) 0.85

Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J Med Virol (2011) 0.83

Novel E6 and E7 oncogenes variants of human papillomavirus type 31 in Brazilian women with abnormal cervical cytology. Infect Genet Evol (2013) 0.80

Interaction of HPV E6 with p53 and associated proteins. Biochem Soc Trans (1994) 0.78

Sequence variation of human papillomavirus type 31 long control region: phylogenetic and functional implications. J Med Virol (2013) 0.77